Analyst Ratings News 16 December 2025

Perpetua Resources (PPTA) Stock News Today: Hatch Named EPCM for Stibnite Gold Project, New Private Placement Details, and Updated Analyst Targets (Dec. 16, 2025)

BOISE, Idaho — December 16, 2025 — Perpetua Resources Corp. (Nasdaq: PPTA / TSX: PPTA) is back in the spotlight today after announcing a major project execution milestone for its flagship Stibnite Gold Project in Idaho: the company has selected

16 December 2025

Analyst Ratings·Investment Updates·Mining Industry·Stock Market News

Southwest Airlines Stock (NYSE: LUV) Surges on Barclays Upgrade: Today’s News, Analyst Forecasts, and Key Risks (Dec. 16, 2025)

Southwest Airlines Co. stock is in the spotlight on Tuesday, Dec. 16, 2025, as shares push higher again—extending a sharp early-December rally that has re-rated the airline in the eyes of momentum traders and (increasingly) Wall Street analysts. In late

16 December 2025

Analyst Ratings·Investment News·Risk Analysis·Stock Market

D-Wave Quantum (QBTS) Stock News on Dec. 16, 2025: Jefferies Starts Coverage With a Buy, Wall Street Targets Stack Up, and the Bull–Bear Tug-of-War Intensifies

D-Wave Quantum Inc. (NYSE: QBTS) is back in the quantum-computing spotlight on December 16, 2025, after Jefferies initiated coverage with a Buy rating and a $45 price target—a fresh endorsement in a sector that’s been equal parts hype engine and

16 December 2025

Analyst Ratings·Investment Strategies·Quantum Computing·Stock Market News

Costco Stock (COST) Slides on Rare Sell Call: Today’s News, Analyst Forecasts, and What to Watch Next (Dec. 16, 2025)

Costco Wholesale Corporation (NASDAQ: COST) is under pressure on Tuesday, December 16, 2025, as investors weigh a rare bearish analyst call against the company’s still-strong fundamentals and recent earnings beat. As of 14:59 UTC on Dec. 16, Costco shares traded

16 December 2025

Analyst Ratings·Company News·Costco·Investing·Stock Market

IonQ Stock News Today (IONQ) — Dec. 16, 2025: Jefferies Starts Coverage With a $100 Target as Shares Rebound After Insider-Sale Headlines

IonQ, Inc. (NYSE: IONQ) is back in motion on December 16, 2025—rebounding after a sharp selloff that was fueled less by a “fundamental surprise” and more by the kind of headline cocktail that makes high-volatility stocks wobble: insider-trading filings, fresh

16 December 2025

Analyst Ratings·Financial News·Investing·Quantum Computing·Stock Market

ServiceNow (NOW) Stock News Today: Armis Deal Talk, Analyst Targets, and the 5-for-1 Split Record Date (Dec. 16, 2025)

December 16, 2025 — ServiceNow, Inc. (NYSE: NOW) is back in the spotlight after a dramatic selloff tied to reported acquisition talks and a fresh wave of Wall Street commentary. On Tuesday, the stock steadied and rebounded after Monday’s steep

16 December 2025

Analyst Ratings·Financial News·Investing·Stock Market

Snap Inc. Stock (SNAP) Today: Latest News, Analyst Price Targets, and Key Catalysts to Watch on Dec. 16, 2025

Snap Inc. (NYSE: SNAP) is heading into mid-December with investors weighing a familiar mix: improving monetization and product momentum on one hand, and regulatory pressure plus uneven advertising performance on the other. Shares were around $7.26 after Monday’s close, with

16 December 2025

Analyst Ratings·Financial News·Investing·Stock Market·Technology Stocks

Uber Stock (UBER) Slides on FTC Uber One Lawsuit as Analysts Hold Bullish Targets — What to Know on Dec. 16, 2025

Uber Technologies, Inc. (NYSE: UBER) stock traded lower on Tuesday, December 16, 2025, as investors digested an escalated regulatory challenge tied to the company’s Uber One subscription program—while Wall Street’s broader outlook on the rideshare and delivery leader stayed notably

16 December 2025

Analyst Ratings·Investment Insights·Legal Issues·Stock Market·Uber News

Bristol-Myers Squibb (BMY) Stock Jumps on Analyst Upgrades, Dividend Hike, and a Catalyst-Rich 2026: What Investors Need to Know on Dec. 16, 2025

Bristol-Myers Squibb Company (NYSE: BMY) is back in the spotlight on December 16, 2025, with the stock trading around $54.29, up roughly 3.6% on the session as optimism builds around Wall Street upgrades, a newly announced dividend increase, and a

16 December 2025

Analyst Ratings·Dividends·Investing·Pharmaceutical Industry·Stock Market

Immunome (IMNM) Stock Today: Phase 3 RINGSIDE Win, $400M Offering, and Fresh Analyst Targets (Dec. 16, 2025)

Immunome, Inc. (NASDAQ: IMNM) is in the spotlight on December 16, 2025, after the company reported positive topline Phase 3 results for its lead desmoid tumor program and then moved to raise significant new capital—two catalysts that can push a

16 December 2025

Analyst Ratings·Biotechnology·Financial News·Investing·Stock Market

Linde plc Stock (LIN) Outlook on Dec. 16, 2025: Latest News, Analyst Price Targets, Dividend Date, and What Could Move Shares Next

Linde plc (Nasdaq: LIN)—the world’s largest industrial gases company—heads into mid-December with a familiar mix of investor emotions: respect for a high-quality, cash-generative business… and impatience about when global industrial activity (especially in Europe) will stop acting like it’s stuck

16 December 2025

Analyst Ratings·Dividend News·Financial Forecasts·Investment Analysis·Stock Market

Genting Singapore (SGX: G13) Stock on 16 Dec 2025: Moody’s Downgrade, RWS 2.0 Funding Questions, and Analyst Targets in Focus

SINGAPORE — December 16, 2025 — Genting Singapore Limited (SGX: G13) is back in the spotlight as investors weigh three intersecting narratives: (1) a fresh credit-rating reset that raises questions about the group’s leverage and cost of capital, (2) the

16 December 2025

Analyst Ratings·Financial News·Investment Insights·Singapore Market·Stock Analysis